ESKKF yields 581.56% · MRK yields 2.76%● Live data
📍 ESKKF pulled ahead of the other in Year 1
Combined, ESKKF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESKKF + MRK for your $10,000?
Etherstack plc, a wireless technology company, engages in licensing mission critical radio technologies to equipment manufacturers and network operators Australia and internationally. Its technology enables push-to-talk (PTT) communications; and advanced digital land mobile radio (LMR), and cellular and satellite networks. The company offers a range of cryptographic solutions, including P25 Security Suite unites AES/DES P25 encryption engine with P25 key fill device (KFD) support for complete P25 subscriber encryption; P25 key management facility; P25 security dongles; and FIPS 140-2 Cryptographic Module, a single-board security device that implements APCO P25 encryption, decryption, and key management and storage services in conformance with FIPS140-2 standards. It also provides defense waveforms, such as technology licensing and transfer, and specialist services; waveform heritage; waveform test and development environment; outsource your risks; and reconfiguration and framework architecture standards. In addition, the company offers LMR network building blocks; APCO P25, dPMR, DMR, MPT1327, and TETRA wireless communications protocol stacks; and tactical and satellite solutions comprising P25 tactical repeaters and IVX PTT IP radio. It serves public safety, defense, utilities, transportation, and resource sectors. The company was formerly known as MM&S (5698) plc and changed its name to Etherstack plc in May 2012. Etherstack plc was incorporated in 2012 and is based in Chippendale, Australia.
Full ESKKF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.